We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

162 hedge funds and large institutions have $537M invested in Anika Therapeutics in 2016 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 14

57% more call options, than puts

Call options by funds: $2.38M | Put options by funds: $1.51M

13% more capital invested

Capital invested by funds: $474M → $537M (+$63.1M)

7% more funds holding

Funds holding: 152 → 162 (+10)

9% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 55

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
162
Holders Change
+10
Holders Change %
+6.58%
% of All Funds
4.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
60
Reduced
55
Closed
14
Calls
$2.38M
Puts
$1.51M
Net Calls
+$864K
Net Calls Change
-$382K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$7.6M
2
FAM
Fred Alger Management
New York
+$5.63M
3
CM
Capital Management
Virginia
+$4.76M
4
HP
HealthInvest Partners
Sweden
+$4.53M
5
NAP
New Amsterdam Partners
New York
+$4.39M

Top Sellers

1
PCM
Portolan Capital Management
Massachusetts
-$14.5M
2
CSC
Cove Street Capital
California
-$12.9M
3
LCP
Lombardia Capital Partners
California
-$8.83M
4
TSW
Thompson Siegel & Walmsley
Virginia
-$8.67M
5
Millennium Management
Millennium Management
New York
-$4.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
151
Zurich Cantonal Bank
Switzerland
$20K – – –
KBC Group
152
KBC Group
Belgium
$18K – – –
MSFP
153
Mark Sheptoff Financial Planning
Connecticut
$13K – – –
SWA
154
Sutton Wealth Advisors
Florida
$11.7K +$10.6K +262 New
MA
155
MCF Advisors
Kentucky
$11K – – –
JP Morgan Chase
156
JP Morgan Chase
New York
$10K – – –
Simplex Trading
157
Simplex Trading
Illinois
$9K -$6.73K -166 -44%
Geode Capital Management
158
Geode Capital Management
Massachusetts
$4.86K +$532K +13,126 +14%
TRCT
159
Tower Research Capital (TRC)
New York
$4K -$20.7K -510 -84%
FIB
160
First Interstate Bank
Montana
$4K – – –
TWA
161
TCI Wealth Advisors
Arizona
$1K +$1.18K +29 New
LCP
162
Lombardia Capital Partners
California
– -$8.83M -231,393 Closed
VAS
163
Valicenti Advisory Services
New York
– -$1.32M -34,675 Closed
RI
164
RTW Investments
New York
– -$1.05M -27,500 Closed
AA
165
ALPS Advisors
Colorado
– -$535K -14,012 Closed
EMG
166
Ellington Management Group
Connecticut
– -$422K -11,049 Closed
Group One Trading
167
Group One Trading
Illinois
– -$410K -10,743 Closed
SCM
168
Stevens Capital Management
Pennsylvania
– -$399K -10,467 Closed
Connor, Clark & Lunn Investment Management (CC&L)
169
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$286K -7,500 Closed
LPL Financial
170
LPL Financial
California
– -$207K -5,378 Closed
Envestnet Asset Management
171
Envestnet Asset Management
Illinois
– -$170K -4,451 Closed
Walleye Trading
172
Walleye Trading
New York
– -$76K -2,000 Closed
LIA
173
LS Investment Advisors
Michigan
– -$19K -495 Closed
Fifth Third Bancorp
174
Fifth Third Bancorp
Ohio
– -$2K -41 Closed
IA
175
IFP Advisors
Florida
– -$1K -20 Closed
4 5 6
7
8

ANIK Hedge Fund Activity: Q1 2016 in Review

162 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2016, worth a combined $537M — up 13% from $474M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ANIK positions and 14 closed out — a net gain of 10 holders — while 60 added to existing stakes and 55 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $7.6M. The largest seller was Portolan Capital Management, cutting an estimated $14.5M.

  • 162 institutional investors held Anika Therapeutics (ANIK) as of Q1 2016, up from 152 in Q4 2015.
  • Funds reported $537M of Anika Therapeutics stock for Q1 2016, up 13% quarter-over-quarter.
  • 24 funds opened new Anika Therapeutics positions in Q1 2016 and 14 closed out, a net change of +10 holders.
  • The largest Anika Therapeutics buyer in Q1 2016 was Renaissance Technologies, an estimated $7.6M added.
  • The largest Anika Therapeutics seller in Q1 2016 was Portolan Capital Management, an estimated $14.5M sold.

Based on aggregated 13F filings for Q1 2016.